Resultats de la cerca - Laura Testa
- Mostrar 1 - 20 resultats de 44
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
-
6
EPV023/#441 Pathologic findings in premenopausal patients with receptor-positive metastatic breast cancer undergoing bilateral salpingo-oophorectomy per Michel Wagner, Cristina Antón, João Paulo Mancusi de Carvalho, Laura Testa, AID Ennes, E Mayerhoff
Publicat 2021Artigo -
7
128P Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in early-stage triple-negative breast cancer: An extracted individual patient data and trial-level meta-analy... per Mariana de Carvalho Leal Gouveia, M.T. Cunha, F. Lazar Neto, Laura Testa, Renata Colombo Bonadio
Publicat 2023Artigo -
8
-
9
Combination of Capecitabine and Oxaliplatin is an Effective Treatment Option for Advanced Neuroendocrine Tumors per Renata Ferrarotto, Laura Testa, Rachel P. Riechelmann, Marina Sahade, Luiz Tenório de Brito Siqueira, Frederico Costa, Paulo M. Hoff
Publicat 2013Artigo -
10
-
11
-
12
-
13
-
14
-
15
-
16
A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53) per Vanessa Petry, Renata Colombo Bonadio, Laura Testa, Daniela JBH. Cohn, Allyne Cagnacci, Roberta G. Campos, Maria Cândida Bv Fragoso, Maria Del Pilar Estevez-Diz
Publicat 2023Artigo -
17
-
18
Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy per Laura Testa, Max S. Mano, Roberto Jun Arai, Renata Colombo Bonadio, Sérgio Serrano, Marina M Costa Zorzetto, Susanne Crocamo, Òren Smaletz, Ruffo Freitas‐Júnior, Paulo M. Hoff
Publicat 2021Artigo -
19
Phase II Trial of Humanized Anti-Lewis Y Monoclonal Antibody for Advanced Hormone Receptor-positive Breast Cancer That Progressed on Previous Endocrine Therapy per Laura Testa, Max S. Mano, Roberto Jun Arai, Renata Colombo Bonadio, Sérgio Serrano, Marina Moreira Costa Zorzetto, Susanne Crocamo, Òren Smaletz, Ruffo Freitas‐Júnior, Paulo M. Hoff
Publicat 2020Pré-impressão -
20
Cardiac Safety of (NEO) Adjuvant Trastuzumab in the Brazilian Community Setting: A Single Center Experience per Leonardo Gomes da Fonseca, Tiago Kenji Takahashi, Milena Perez Mak, Romualdo Barroso‐Sousa, Laura Testa, V. Petry Helena, Ronaldo Rodrigues da Costa, Paulo M. Hoff, Max S. Mano
Publicat 2012Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Cancer
Oncology
Breast cancer
Chemotherapy
Triple-negative breast cancer
Biology
Gynecology
Disease
Paleontology
Stage (stratigraphy)
Immunotherapy
Metastatic breast cancer
Proportional hazards model
Cardiology
Confidence interval
Coronavirus disease 2019 (COVID-19)
Environmental health
Hazard ratio
Immunology
Infectious disease (medical specialty)
Pembrolizumab
Population
Adjuvant
Adverse effect
Clinical trial
Randomized controlled trial
Surgery
2019-20 coronavirus outbreak